NCT01522625View on ClinicalTrials.gov

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

November 30, 2018

Study Completion Date

December 31, 2018

Conditions
Chronic Hepatitis B
Interventions
DRUG

tenofovir disoproxil fumarate 300mg per day

tenofovir disoproxil fumarate 300mg per day for 3 years

DRUG

Placebo

Placebo, identical to TDF in appearance, once daily for 3years

Trial Locations (6)

104

Mackay Memorial Hosp, Taipei

407

Taichung Veterans General Hospital, Taichung

539

Chia-Yi Christine Hospital, Chiayi City

640

National Taiwan University Hospital Yun-Lin Branch, Yunlin

824

E-Da Hospital, Kaohsiung City

Unknown

Chi Mei Medical Center, Liouying, Tainan City

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

Taipei Institute of Pathology

OTHER_GOV

lead

E-DA Hospital

OTHER